Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae-Cheol Lee

Showing results (141-150 of 226) with videos related to

Pageof 23
Sort By:
Experimental & Molecular Medicine|May 30, 2015
An important role for peroxiredoxin II in survival of A549 lung cancer cells resistant to gefitinibTaeho Kwon, Jin Kyung Rho, Jae Cheol Lee, et al.
Thoracic Cancer|March 22, 2021
Diagnostic yield and safety of biopsy guided by electromagnetic navigation bronchoscopy for high-risk pulmonary nodulesJu Hyun Oh, Chang-Min Choi, Seulgi Kim, et al.
Journal of Medicinal Chemistry|November 2, 2017
Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based DesignShinmee Mah, Jung Hee Park, Hoi-Yun Jung, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2008
A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancerIm Il Na, Tae Hyun Lee, Du Hwan Choe, et al.
Lung Cancer (Amsterdam, Netherlands)|December 21, 2010
Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIsJin-Haeng Chung, Jin Kyung Rho, Xianhua Xu, et al.
BMC Cancer|July 9, 2016
Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexedSojung Park, Hyun Jung Kim, Chang-Min Choi, et al.
Translational Oncology|April 29, 2019
Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching AnalysisByung Woo Yoon, Jae Hoon Kim, Seung Hyeon Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 15, 2010
Association between age at diagnosis and the presence of EGFR mutations in female patients with resected non-small cell lung cancerYoon Hee Choi, Jin Kyung Lee, Hye Jin Kang, et al.
Plos One|March 18, 2015
AUY922 effectively overcomes MET- and AXL-mediated resistance to EGFR-TKI in lung cancer cellsYun Jung Choi, Seon Ye Kim, Kwang Sup So, et al.
Biomolecules & Therapeutics|October 12, 2013
Destabilization of TNF-α mRNA by RapamycinJong-Woo Park, Ye Ji Jeon, Jae Cheol Lee, et al.
Pageof 23

Showing results (141-150 of 226) with videos related to

Sort By:
Pageof 23
Experimental & Molecular Medicine|May 30, 2015
An important role for peroxiredoxin II in survival of A549 lung cancer cells resistant to gefitinibTaeho Kwon, Jin Kyung Rho, Jae Cheol Lee, et al.
Thoracic Cancer|March 22, 2021
Diagnostic yield and safety of biopsy guided by electromagnetic navigation bronchoscopy for high-risk pulmonary nodulesJu Hyun Oh, Chang-Min Choi, Seulgi Kim, et al.
Journal of Medicinal Chemistry|November 2, 2017
Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based DesignShinmee Mah, Jung Hee Park, Hoi-Yun Jung, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2008
A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancerIm Il Na, Tae Hyun Lee, Du Hwan Choe, et al.
Lung Cancer (Amsterdam, Netherlands)|December 21, 2010
Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIsJin-Haeng Chung, Jin Kyung Rho, Xianhua Xu, et al.
BMC Cancer|July 9, 2016
Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexedSojung Park, Hyun Jung Kim, Chang-Min Choi, et al.
Translational Oncology|April 29, 2019
Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching AnalysisByung Woo Yoon, Jae Hoon Kim, Seung Hyeon Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 15, 2010
Association between age at diagnosis and the presence of EGFR mutations in female patients with resected non-small cell lung cancerYoon Hee Choi, Jin Kyung Lee, Hye Jin Kang, et al.
Plos One|March 18, 2015
AUY922 effectively overcomes MET- and AXL-mediated resistance to EGFR-TKI in lung cancer cellsYun Jung Choi, Seon Ye Kim, Kwang Sup So, et al.
Biomolecules & Therapeutics|October 12, 2013
Destabilization of TNF-α mRNA by RapamycinJong-Woo Park, Ye Ji Jeon, Jae Cheol Lee, et al.
Pageof 23